BioScience Health Innovations annual ebitda
2022
2023
2024
2025
BioScience Health Innovations EBITDA Growth & History (BHIC)
BioScience Health Innovations's calculated EBITDA was $719,051 for fiscal 2025.
View full BioScience Health Innovations company overviewBioScience Health Innovations annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $719,051 | $632,051 | +726.50% |
| 2024 | 2024-12-31 | $87,000 | $338,500 | — |
| 2023 | 2023-12-31 | −$251,500 | −$81,050 | — |
| 2022 · Dec 31 | 2022-12-31 | −$170,450 | — | — |
BioScience Health Innovations quarterly ebitda
Q4.24
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$217,882 | −$675,586 | — |
| Q1 2026 | 2026-03-31 | −$229,907 | −$656,705 | — |
| Q4 2025 | 2025-12-31 | −$156,669 | −$166,626 | — |
| Q2 2025 | 2025-06-30 | $457,704 | — | — |
| Q1 2025 | 2025-03-31 | $426,798 | — | — |
| Q4 2024 | 2024-12-31 | $9,957 | — | — |
BioScience Health Innovations ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, BioScience Health Innovations's ebitda increased from −$170,450 to $719,051, a change of $889,501. The latest reported quarter, Q2 2026, shows −$217,882.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioScience Health Innovations source filings ↗